Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

65.99
-2.4931-3.64%
Volume:3.96M
Turnover:267.93M
Market Cap:11.74B
PE:-55.49
High:69.48
Open:68.32
Low:65.53
Close:68.48
52wk High:104.32
52wk Low:31.36
Shares:177.91M
Float Shares:101.68M
Volume Ratio:0.74
T/O Rate:3.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1891
EPS(LYR):-6.2273
ROE:-72.61%
ROA:-9.08%
PB:23.12
PE(LYR):-10.60

Loading ...

Tempus AI Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 21

Tempus AI Inc : TD Cowen Cuts to Hold From Buy; Raises Target Price to $88 From $72

THOMSON REUTERS
·
Oct 21

Post-Bell | Wall St Ends Sharply Higher; Apple Surges 4%; Netflix Jumps 3%; Tesla, Meta and Amazon Gain 2%

Tiger Newspress
·
Oct 21

Why Tempus AI Stock Raced More Than 5% Higher Today

Motley Fool
·
Oct 21

Tempus AI Shares Are Trading Higher Monday: What's Going On?

Benzinga_recent_news
·
Oct 21

AI Software Shares Rallied. Tempus up 7%; C3.ai up 5%; SoundHound AI, Shopify, Salesforce and Datadog up 3%; HubSpot, BigBear.ai and Palantir up 2%

Tiger Newspress
·
Oct 20

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Oct 20

AI Biotech Stocks Shined. Recursion Up 15%; Beam Up 14%; Tempus Up 7%; Novavax Up 6%; Crispr And Ginkgo Up 4%; Hims Up 2%

Tiger Newspress
·
Oct 20

Ambry Genetics Unveils Decade-Long Genetic Study to Advance Healthcare Equity

Reuters
·
Oct 20

Canaccord Genuity Initiates Coverage on Tempus AI With Buy Rating, $110 Price Target

MT Newswires Live
·
Oct 20

Tempus AI Initiated at Buy by Canaccord Genuity

Dow Jones
·
Oct 20

Tempus AI initiated with a Buy at Canaccord

TIPRANKS
·
Oct 20

IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?

Benzinga_recent_news
·
Oct 19

Whitehawk Shares Rise After Forming Collaboration With Tempus AI to Advance Oncology Research

MT Newswires Live
·
Oct 16

Tempus Announces Collaboration With WhiteHawk Therapeutics to Advance Biomarker-Driven Oncology Research

THOMSON REUTERS
·
Oct 16

Tempus AI Announces New Clinical Trial Findings on Precision Cancer Treatments to Be Presented at ESMO Congress 2025

Reuters
·
Oct 15

Nancy Pelosi, Cathie Wood Align On These 4 Stocks – Do You Own Any?

Benzinga_recent_news
·
Oct 11

Why Tempus AI (TEM) Is Up 11.2% After Securing ARPA-H Precision Cancer Therapy Collaboration

Simply Wall St.
·
Oct 11

Tempus AI selected by ARPA-H to provide CRO services

TIPRANKS
·
Oct 09

BRIEF-Tempus AI Inc - Selected By ARPA-H To Provide CRO And Testing Services For The Adapt Program

Reuters
·
Oct 09